1. Bakogeorgos M, Mountzios G, Kotsantis G, Economopoulou P, Fytrakis N. Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: A single institution comparative study. JBUON 2013;18:629–34.
2. Mohile SG, Dale W, Somerfield MR, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018 Aug 1;36(22):2326-2347. doi: 10.1200/JCO.2018.78.8687.
3. Seghers PAL, Alibhai SMH, Battisti NML, et al. Geriatric assessment for older people with cancer: policy recommendations. Glob Health Res Policy. 2023 Sep 1;8(1):37. doi: 10.1186/s41256-023-00323-0.
4. DuMontier C, Loh KP, Soto-Perez-de-Celis E, Dale W. Decision Making in Older Adults With Cancer. J Clin Oncol. 2021 Jul 1;39(19):2164-2174. doi: 10.1200/JCO.21.00165.
5. Balducci L, Extermann M. Management of Cancer in the Older Person: A Practical Approach. The Oncologist 2000;5:224–37
6. Bouleftour W, Tinquaut F, Lafaie L. Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort. Cancer Invest. 2024 May;42(5):416-424. doi: 10.1080/07357907.2024.2357166.
7. Kim J, Hurria A. Determining chemotherapy tolerance in older patients with cancer. J Natl Compr Canc Netw. 2013 Dec 1;11(12):1494-502. doi: 10.6004/jnccn.2013.0176.
8. Hohenegger, M. Pharmacokinetic considerations in geriatric cancer patients. memo 14, 11–14 (2021). https://doi.org/10.1007/s12254-020-00668-z
9. Peterson LL, Hurria A, Feng T, et al. Association between renal function and chemotherapy-related toxicity in older adults with cancer. J Geriatr Oncol. 2017 Mar;8(2):96-101. doi: 10.1016/j.jgo.2016.10.004.
10. He X, Clarke SJ, McLachlan AJ. Clinical pharmacology of chemotherapy agents in older people with cancer. Curr Gerontol Geriatr Res. 2011;2011:628670. doi: 10.1155/2011/628670.
11. Gironés Sarrió R, Molina Garrido MJ, Guillén-Ponce C, Blanco R, Gonzalez Flores E, Saldaña J. General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force’s position statement. Clin. Transl. Oncol. 2018;20:1246–51
12. Oliveira RF, Oliveira AI, Cruz AS, Ribeiro O, Afreixo V, Pimentel F. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors. BMC Geriatr. 2024 Jun 25;24(1):557. doi: 10.1186/s12877-024-05135-6.
13. Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L. Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. J Geriatr Oncol. 2014 Jul;5(3):307-14. doi: 10.1016/j.jgo.2014.04.002.
14. Bandini A, Calabrò PF, Banchi M, Orlandi P, Bocci G. Metronomic Chemotherapy in Elderly Patients. Curr Oncol Rep. 2024 Apr;26(4):359-376. doi: 10.1007/s11912-024-01505-w.
15. Owlia F, Kazemeini SK, Gholami N. Prevention and management of mucositis in patients with cancer: a review article. Iran J Cancer Prev. 2012 Fall;5(4):216-20.
16. Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, et al. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2015;33:3199–212
17. Klastersky JA, Dal Lago L, Lalami Y. Use of granulocyte-colony stimulating factors in older patients: a review of recently published data. Curr Opin Oncol. 2020 Jul;32(4):258-261. doi: 10.1097/CCO.0000000000000632.
18. Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H. Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients. Onco Targets Ther. 2016 Oct 28;9:6689-6693. doi: 10.2147/OTT.S104743.
19. Bohlius J, Bohlke K, Castelli R, et al. Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142.
20. Balducci L, Dolan D, Hoffe SA. Palliative Care in Older Patients with Cancer. Cancer Control J. Moffitt Cancer Cent. 2015;22:480–8.